Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling
Watzky, Manon, Huard, Solène, Juricek, Ludmila, Dairou, Julien, Chauvet, Caroline, Coumoul, Xavier, Letessier, Anne, Miotto, Benoit
Published in Nucleic acids research (10.06.2022)
Published in Nucleic acids research (10.06.2022)
Get full text
Journal Article
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
Suresh, Samyuktha, Huard, Solène, Brisson, Amélie, Némati, Fariba, Dakroub, Rayan, Poulard, Coralie, Ye, Mengliang, Martel, Elise, Reyes, Cécile, Silvestre, David C, Meseure, Didier, Nicolas, André, Gentien, David, Fayyad-Kazan, Hussein, Le Romancer, Muriel, Decaudin, Didier, Roman-Roman, Sergio, Dubois, Thierry
Published in Cancers (01.01.2022)
Published in Cancers (01.01.2022)
Get full text
Journal Article
Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis
Cômes, Pierre-Cyril, Le Van, Tuan, Tran, Suzanne, Huard, Solène, Abi-Jaoude, Samiya, Venot, Quitterie, Marijon, Pauline, Boetto, Julien, Blouin, Antoine, Bielle, Franck, Ducos, Yohan, Teranishi, Yu, Kalamarides, Michel, Peyre, Matthieu
Published in Cancer gene therapy (01.08.2023)
Published in Cancer gene therapy (01.08.2023)
Get full text
Journal Article
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
Dakroub, Rayan, Huard, Solene, Hajj-Younes, Yara, Suresh, Samyuktha, Badran, Bassam, Fayyad-Kazan, Hussein, Dubois, Thierry
Published in Breast cancer targets and therapy (30.11.2023)
Published in Breast cancer targets and therapy (30.11.2023)
Get full text
Journal Article
Abstract 4031: PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer
Suresh, Samyuktha, Huard, Solène, Némati, Fariba, Dakroub, Rayan, Nicolas, André, Meseure, Didier, Decaudin, Didier, Roman-Roman, Sergio, Dubois, Thierry
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article